Literature DB >> 8396266

At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide.

J Bukh1, R H Purcell, R H Miller.   

Abstract

In a previous study we sequenced the 5' noncoding (NC) region of 44 isolates of hepatitis C virus (HCV) and identified heterogeneous domains that provided evidence for additional genetic groups of HCV not previously recognized. In this study we have determined the complete nucleotide sequence of the putative envelope 1 (E1) gene in 51 HCV isolates from around the world and found that they could be grouped into at least 12 distinct genotypes. The E1 gene sequence of 8 of these genotypes has not been reported previously. Although the genetic relatedness of HCV isolates determined by the previous analysis of the 5' NC region predicted the relationships observed in the E1 gene, analysis of the 5' NC sequence alone did not accurately predict all HCV genotypes. The nucleotide and amino acid sequence identities of the E1 gene among HCV isolates of the same genotype were in the range of 88.0-99.1% and 89.1-98.4%, respectively, whereas those of HCV isolates of different genotypes were in the range of 53.5-78.6% and 49.0-82.8%, respectively. The latter differences are similar to those found when comparing the envelope gene sequences of the various serotypes of the related flaviviruses as well as other RNA viruses. We found that some genotypes of HCV were widely distributed around the world, whereas others were identified only in discreet geographical regions. Four genotypes were identified exclusively in Africa and comprised the majority of HCV isolates on that continent. The E1 gene was exactly 576 nucleotides in length in all 51 HCV isolates with no in-frame stop codons. Analysis of the predicted E1 protein identified several conserved domains that may be important for maintaining its biological function: (i) eight invariant cysteine residues, (ii) three potential N-linked glycosylation sites, (iii) a domain of nine amino acids (GHRMAWDMM), and (iv) an amino acid doublet (GV) near the putative cleavage site at the C terminus of the protein. In conclusion, the discovery of at least 12 genotypes of HCV has important implications for HCV diagnosis and vaccine development.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396266      PMCID: PMC47323          DOI: 10.1073/pnas.90.17.8234

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  A new type of hepatitis C virus in patients in Thailand.

Authors:  S Mori; N Kato; A Yagyu; T Tanaka; Y Ikeda; B Petchclai; P Chiewsilp; T Kurimura; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1992-02-28       Impact factor: 3.575

2.  Identification of hepatitis C viruses with a nonconserved sequence of the 5' untranslated region.

Authors:  C H Lee; C Cheng; J Wang; L Lumeng
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

3.  At least five related, but distinct, hepatitis C viral genotypes exist.

Authors:  T A Cha; E Beall; B Irvine; J Kolberg; D Chien; G Kuo; M S Urdea
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

4.  Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability.

Authors:  H Okamoto; M Kojima; S Okada; H Yoshizawa; H Iizuka; T Tanaka; E E Muchmore; D A Peterson; Y Ito; S Mishiro
Journal:  Virology       Date:  1992-10       Impact factor: 3.616

5.  Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay.

Authors:  J Bukh; R H Purcell; R H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

6.  Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes.

Authors:  H Okamoto; K Kurai; S Okada; K Yamamoto; H Lizuka; T Tanaka; S Fukuda; F Tsuda; S Mishiro
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

7.  Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants.

Authors:  S W Chan; F McOmish; E C Holmes; B Dow; J F Peutherer; E Follett; P L Yap; P Simmonds
Journal:  J Gen Virol       Date:  1992-05       Impact factor: 3.891

8.  Sequence analysis of the 5' noncoding region of hepatitis C virus.

Authors:  J Bukh; R H Purcell; R H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

9.  Genomic typing of hepatitis C viruses present in China.

Authors:  K Liu; Z Hu; H Li; A M Prince; G Inchauspe
Journal:  Gene       Date:  1992-05-15       Impact factor: 3.688

10.  Molecular cloning of hepatitis C virus genome from a single Japanese carrier: sequence variation within the same individual and among infected individuals.

Authors:  T Tanaka; N Kato; M Nakagawa; Y Ootsuyama; M J Cho; T Nakazawa; M Hijikata; Y Ishimura; K Shimotohno
Journal:  Virus Res       Date:  1992-04       Impact factor: 3.303

View more
  107 in total

1.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

2.  Phylogenetic analysis of hepatitis C virus isolates from Tunisian patients.

Authors:  Ahlem Djebbi; Selma Mejri; Valerie Thiers; Henda Triki
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

3.  Recent advances in laboratory diagnosis of hepatitis C virus infection.

Authors:  R Chaudhary
Journal:  Can J Infect Dis       Date:  1994-11

4.  Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein.

Authors:  Kousuke Nakai; Toru Okamoto; Tomomi Kimura-Someya; Koji Ishii; Chang Kweng Lim; Hideki Tani; Eiko Matsuo; Takayuki Abe; Yoshio Mori; Tetsuro Suzuki; Tatsuo Miyamura; Jack H Nunberg; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

5.  Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase.

Authors:  R Bartenschlager; L Ahlborn-Laake; K Yasargil; J Mous; H Jacobsen
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

6.  Kinetic and structural analyses of hepatitis C virus polyprotein processing.

Authors:  R Bartenschlager; L Ahlborn-Laake; J Mous; H Jacobsen
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

7.  Human monoclonal antibodies for the immunological characterization of a highly conserved protein domain of the hepatitis C virus glycoprotein E1.

Authors:  K Siemoneit; M da S Cardoso; K Koerner; A Wölpl; B Kubanek
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

8.  Selection of more pathogenic hepatitis C virus genotype II during long-term follow-up of interferon-treated patients.

Authors:  E Villa; P Buttafoco; A Merighi; A Grottola; I Ferretti; A Ferrari; F Callea; P Trande; A M Rebecchi; F Manenti
Journal:  J Mol Med (Berl)       Date:  1995-05       Impact factor: 4.599

9.  HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.

Authors:  M J Koziel; D Dudley; N Afdhal; A Grakoui; C M Rice; Q L Choo; M Houghton; B D Walker
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

10.  Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus.

Authors:  R Ray; A Khanna; L M Lagging; K Meyer; Q L Choo; R Ralston; M Houghton; P R Becherer
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.